Draft Genome Sequences of the Probiotic Enterococcus faecalis Symbioflor 1 Clones DSM16430 and DSM16434 by Fritzenwanker, Moritz et al.
Draft Genome Sequences of the Probiotic Enterococcus faecalis
Symbioflor 1 Clones DSM16430 and DSM16434
Moritz Fritzenwanker,a Anindita Chakraborty,a* Torsten Hain,a Kurt Zimmermann,b Eugen Domanna
Institute of Medical Microbiology, German Centre for Infection Research (DZIF Partner Site Giessen-Marburg-Langen), Justus-Liebig-University Giessen, Giessen,
Germanya; SymbioGruppe GmbH & Co KG, Herborn, Germanyb
* Present address: Anindita Chakraborty, Institute of Virology, Technical University of Munich, Munich, Germany.
The probiotic Symbioflor 1 is a historical concoction of 10 isolates of Enterococcus faecalis. Pulsed-field gel electrophoresis re-
vealed two groups: one comprising eight identical clones (DSM16430, DSM16432, DSM16433, DSM16435 to DSM16439) and a
further two isolates (DSM16431, DSM16434) with marginally different profiles. Here, we report a comparative analysis of the
draft genome sequences of representative isolates.
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The homeostasis of gut microbiota is essential for the mainte-nance of health, and infectious or metabolic imbalance can
lead to gastrointestinal disorders (1–3). Modulation of the gut
microbiota to prevent disease is therefore an area of great interest.
The conceptual use of beneficial probiotic bacteria in regulating
intestinal dysbiosis has been propagated, and the use of these mi-
croorganisms has been implicated in promoting health following
consumption (4, 5).
The commercially available probiotic Symbioflor 1 (Symbio-
Pharm, Herborn, Germany) comprises 10 probiotic Enterococcus
faecalis isolates obtained from a healthy volunteer in the early
1950s. Enterococci spp. are Gram-positive, facultative anaerobic
cocci that reside as commensals in the oral cavity, vagina, and
gastrointestinal tract of humans. These bacteria can cause a broad
range of diseases, including urinary tract infections, endocarditis,
and peritonitis (6). However, species of the genus Enterococcus
have gained great interest due to their dual-faced status of being a
common commensal in the human microbiota as well as display-
ing pathogenic traits (7). Enterococci spp. have been used as start-
ers or probiotic cultures that are commonly found in traditional
Mediterranean food and fermented food (4, 8). Symbioflor 1 has
been prescribed since 1954 in Germany as a pharmaceutical
preparation intended to improve the microbial balance of the intes-
tinal flora with no records of pathogenic incidents (9). Analytical
pulsed-field gel electrophoresis (restriction enzyme SmaI fingerprint-
ing) of the 10 isolates (DSM16430 to DSM16439) revealed eight iden-
tical clones (DSM16430, DSM16432, DSM16433, DSM16435 to
DSM16439) and a further two isolates (DSM16431, DSM16434)
exhibiting marginal differences. The complete genome sequence
of one of these isolates, DSM16431, has been described previously
(10). We determined the sequence of DSM16430 as a representa-
tive of the eight identical isolates together with DSM16434 and
performed comparative genomics.
DNA sequencing libraries were prepared using the Nextera XT
kit (Illumina, San Diego, CA, USA) according to the manufactur-
er’s instructions. Individually tagged libraries were sequenced as a
part of a flow cell on the Illumina MiSeq platform with v3 chem-
istry (2 300 bp). Genomes were assembled with CLC Genomics
Workbench and compared with Mauve (11).
For DSM16434 we generated 1,850,276 reads with an average
length of 183 bp (gapped genome size: 2,763,070 bp). Mauve
analysis (at least 90% identity and coverage) revealed ~99%
identity with the genome of DSM16431 (10). The genome of
DSM16430 was assembled to a gapped genome of 2,633,486 bp in
size from a total of 2,270,870 reads with an average length of
179 bp. Comparative genome analysis indicated that the three
genomes are highly homologous, sharing a core genome of ~88%
(2,468 open reading frames). The genome size of DSM16430 is
smallest and lacks two regions present in the other isolates. This
includes a region of ~100 kb in size lacking multiple transposases
as well as the aggregation substance; the smaller gap had a size of
~36 kb, and represented the loss of a region encoding for a pro-
phage.
Our data indicate a clonal origin for the 10 E. faecalis isolates
found in Symbioflor 1 and suggests that this probiotic preparation
could effectively be reduced to a combination of only two clonal
strains, DSM16430 and DSM16431.
Accession number(s). These whole-genome shotgun proj-
ects have been deposited in the European Nucleotide Archive
under the accession numbers FLUS00000000 (DSM16430) and
FLUT00000000 (DSM16434). The versions described in this pa-
per are the first versions, FLUS01000000 and FLUT01000000.
ACKNOWLEDGMENT
We thank Christina Gerstmann for excellent technical assistance.
FUNDING INFORMATION
This work was funded by the German Ministry of Education and Research
(BMBF) as part of the research consortium ANTHONIA to E.D. (grant
no. 0315379A). The funders had no role in study design, data collection
and interpretation, or the decision to submit the work for publication.
crossmark
Genome AnnouncementsSeptember/October 2016 Volume 4 Issue 5 e01061-16 genomea.asm.org 1
 o
n
 O
ctober 23, 2017 by UNIVERSITATSBIBLIO
THEK G
IESSEN
http://genom
ea.asm
.org/
D
ow
nloaded from
 
REFERENCES
1. Cho I, Blaser MJ. 2012. The human microbiome: at the interface of health
and disease. Nat Rev Genet 13:260–270. http://dx.doi.org/10.1038/nrg3182.
2. Lloyd-Price J, Abu-Ali G, Huttenhower C. 2016. The healthy human
microbiome. Genome Med 8:51. http://dx.doi.org/10.1186/s13073-016
-0307-y.
3. McKenney ES, Kendall MM. 2016. Microbiota and pathogen “pas de
deux”: setting up and breaking down barriers to intestinal infection.
Pathog Dis 74:ftw051. http://dx.doi.org/10.1093/femspd/ftw051.
4. Fijan S. 2014. Microorganisms with claimed probiotic properties: an over-
view of recent literature. Int J Environ Res Public Health 11:4745– 4767.
http://dx.doi.org/10.3390/ijerph110504745.
5. McCarville JL, Caminero A, Verdu EF. 2016. Novel perspectives on
therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol
9:580 –593. http://dx.doi.org/10.1177/1756283X16637819.
6. Teixeira LM, Carvalho Mda G, Facklam RR, Shewmaker PL. 2015.
Enterococcus, p. 403– 421. In Jorgensen JH, Pfaller MA, Carroll KC, Funke
G, Landry ML, Richter SS, Warnock DW (ed.), Manual of clinical micro-
biology, vol. 1, 11th ed. ASM Press, Washington, DC. http://dx.doi.org/
10.1128/9781555817381.ch23.
7. Christoffersen TE, Jensen H, Kleiveland CR, Dørum G, Jacobsen M,
Lea T. 2012. In vitro comparison of commensal, probiotic and pathogenic
strains of Enterococcus faecalis. Br J Nutr 108:2043–2053. http://
dx.doi.org/10.1017/S0007114512000220.
8. Ouwehand AC, Salminen S, Isolauri E. 2002. Probiotics: an overview of
beneficial effects. Antonie Van Leeuwenhoek 82:279 –289. http://
dx.doi.org/10.1023/A:1020620607611.
9. Domann E, Hain T, Ghai R, Billion A, Kuenne C, Zimmermann K,
Chakraborty T. 2007. Comparative genomic analysis for the presence of
potential enterococcal virulence factors in the probiotic Enterococcus
faecalis strain Symbioflor 1. Int J Med Microbiol 297:533–539. http://
dx.doi.org/10.1016/j.ijmm.2007.02.008.
10. Fritzenwanker M, Kuenne C, Billion A, Hain T, Zimmermann K,
Goesmann A, Chakraborty T, Domann E. 2013. Complete genome se-
quence of the probiotic Enterococcus faecalis Symbioflor 1 clone DSM
16431. Genome Announc 1(1):e00165-12. http://dx.doi.org/10.1128/
genomeA.00165-12.
11. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple ge-
nome alignment with gene gain, loss and rearrangement. PLoS One
5:e11147. http://dx.doi.org/10.1371/journal.pone.0011147.
Fritzenwanker et al.
Genome Announcements2 genomea.asm.org September/October 2016 Volume 4 Issue 5 e01061-16
 o
n
 O
ctober 23, 2017 by UNIVERSITATSBIBLIO
THEK G
IESSEN
http://genom
ea.asm
.org/
D
ow
nloaded from
 
